Clinical study to evaluate the safety and efficacy of cinnamon in the management of non-alcoholic fatty liver disease
Phase 2
Completed
- Conditions
- Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
- Registration Number
- CTRI/2021/03/032039
- Lead Sponsor
- Central council for research in Unani medicine New dehli
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
USG documented grade 1 and grade 2 non-alcoholic fatty liver disease.
Patients with dull ache/ heaviness in the right hypochondriac region.
Patients with symptoms of dyspepsia and malaise.
BMI less than 34.9kg/metre square.
Patients who are willing to give consent.
Exclusion Criteria
Alcoholic liver disease.
Grade 3 fatty liver disease and above.
Patients with cardiovascular and renal diseases.
Patients having focal fatty liver cirrhosis and known cases of hepatitis and other liver morbidities.
Patients having cholelithiasis and cholecystitis.
BMI greater than 34.9kg/meter square.
Pregnant and lactating women.
Patients having endocrine disorders like diabetes mellitus.
Patients on lipid lowering drugs/statins.
Patients who fail to give consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relief in signs and symptoms of non alcoholic fatty liver diseaseTimepoint: 60 days
- Secondary Outcome Measures
Name Time Method Radiological and biochemical assessmentTimepoint: 60 days